BAIQ CIPTA HARDIANTI 22010111140197 Lap.KTI Bab8

(1)

56

DAFTAR PUSTAKA

1. Price Sylvia A, Wilson Lorraine M. Patofisiologi: Konsep Klinis

Proses-Proses Penyakit. Jakarta: EGC; 2012.

2. Doshani A, Teo RE, Mayne CJ, Tincello DG. Uterine prolapse. BMJ:

British Medical Journal [internet]. 2007. [cited 2014 Des 8];

335:819-823.

3. Detollenaere RJ, Boon J, Stekelenburg J, Alhafidh AH, Hakvoort RA,

Vierhout ME, et al. Treatment of Uterine Prolapse Stage 2 or Higher:

A Randomized Multicenter Trial Comparing Sacrospinnosus Fixation

with Vaginal Hysterectomy (SAVE U trial). BMC Womens Health

Journal [internet]. 2011. [cited 2014 Nov 27]; 11(4). Available from:

http://www.biomedcentral.com/1472-6874/11/4

4. Barsoom RS, Dyne PL. Uterine Prolapse in Emergency Medicine.

Medscape Article. [internet]. 2013. [cited 2014 Nov 27 ]. Available

from:http://emedicine.medscape.com/article/797295 overview#showall

5. Pratiwi M, Yoga K, Putra IGM. Pelvic Organ Prolapse. E-Jurnal

Medika Udayana [internet]. 2013 [cited 2014 Des 10]; 2(4):709-736.

6. Kasiati K, Lestari D, Hardianto G. Analisis Faktor yang Berhubungan

dengan Kejadian Prolaps Uteri pada Pasien Kunjungan Baru di Poli

Kandungan RSUD Dr. Soetomo Surabaya. Wahana Riset Kesehatan;

2011.


(2)

8. Worku F, Gebresilassie S. Reproductive Health for Science Students.

In collaboration with The Carter Canter (EPHTI) and The Federal

Democratic Republic of Ethiopia Ministry of Education and Ministry

of Health. University of Gondar; 2008.

9. Anwar Mochamad, Baziad Ali, Prabowo R. Prajitno. Ilmu Kandungan:

Kelainan Letak Alat-Alat Genital. Jakarta: PT Bina Pustaka Sarwono

Prawirohardjo; 2011.

10.Werner C, Moschos E, Griffith W, Beshay V, Rahn D, Richardson D,

et al. Williams Gynecology Study Guide, 2nd ed. United States: Mc

Graw Hill Professional; 2012.

11.Shrestha B, Onta S, Choulagai B, Poudyal A, Pahari DP, Uprety A, et

al. Women’s experiences and health care-seeking practices in relation to uterine prolapse in a hill district of Nepal. BMC Women's Health

[internet]. 2014. [cited 2015 Jan 31]. Available from:

http://www.biomedcentral.com/1472-6874/14/20

12.Shrestha A D, Lakhey B, Sharma J, Singh M, Singh S, Shresta B.

Study team: Prevalence of Uterine Prolapse amongst Gynecology OPD

Patients in Tribhuvan University Teaching Hospital in Nepal and its

Socio‐Cultural Determinants. Case Study 1 Nepal; 2012.

13.Sharma A, Zhang J P. Risk Factors and Symptoms of Uterine

Prolapse: Reality of Nepali Women; 2014.

14.Nizomy IR, Prabowo RP, Hardianto G. Correlation between Risk


(3)

Dr. Soetomo Hospital Surabaya, 2007-2011. Department of Obstetric

& Gynecology Faculty of Medicine, Airlangga University [internet].

2013. [cited 2015 Feb 14]; 21(2):61-66

15.Kuncharapu I, Majeroni BA, Johnson DW. Pelvic Organ Prolapse.

American Academy of Family Physician. 2010;81(9).

16.(https://www.cia.gov/library/publications/the-world

factbook/geos/id.html),

17.Noerpramana, Noor Pramono, Hadijono, R Soerjo, Iskandar, T. Mirza,

Kristanto Herman, Hidayat, Syarief Thaufik, Erwinanto. Praktis Klinis

Obstetri Ginekologi. Semarang: Cakrawala Media; 2013.

18.Berek, Jonathan S. Berek & Novak’s Gynecology 15th ed. Lippincott Williams & wilkins; 2012.

19.Siregar Nurhasidan. Faktor-faktor yang Mempengaruhi Pengetahuan

Ibu tentang Prolapsus Uteri di Rumah Sakit Umum Kesdam Iskandar

Muda Banda Aceh. STIKesU’Budiyah Banda Aceh; 2013.

20.Snell RS. Anatomi Klinis: Berdasarkan Sistem. Jakarta: EGC; 2012.

21.Cunningham FG, Leveno KJ, Bloom SL, Spong CY, Dashe JS,

Hoffman BL, Williams Obstetrics 24th Edition iInternet]. United

States: Mc Graw Hill; 2014. [cited 2014 Des 12]. Available from:

www.mhprofessional.com.

22.Chamberlain Geoffrey, Steer PJ. Turnbull’s Obstetrics 3rd ed. London: Churchill Livingstone; 2002.


(4)

23.Drake RL, Vogl AW, Mitchell AWM, Gray’s Anatomy for Students, 3rd ed. [internet]. London: Churchill Livingstone; 2014 [cited 2015

Jan 13]. Available from:

http://www.hopkinsmedicine.org/mcp/education/300.713%20lectures/

2014/byung_kang_pelvis_09.15.2014.pdf

24.Wahyudi. Distribusi Staging dan Faktor Risiko Prolapsus Organ Pelvis

di Poliklinik Ginekologi RS H. Adam Malik / RS dr. Pirngadi Medan

Berdasar Sistem POPQ. USU e-Repository; 2008.

25.Milton S. Hershey Medical Center. Uterine Prolapse [internet]. 2013.

[updated 2013 Aug 5; cited 2015 Jan 28]. Available from:

http://pennstatehershey.adam.com/content.aspx?productId=117&pid=1

&gid=001508

26.Marta, KF. Hubungan Antara Prolaps Organ Panggul dengan Ukuran

Panggul Perempuan Suku Bali. Fakultas Kedokteran Universitas

Udayana Denpasar; 2011.

27.Handa VL, Blomquist JL, McDermott KC, Friedman S, Munoz A.

Pelvic Floor Disorders After Childbirth: Effect of Episiotomy, Perineal

Laceration, and Operative Birth. National Institutes of Health Obstet

Gynecol; 2012. [cited 2015 Feb 20]; 119(2)

28.DeCherney AH, Nathan L. Current Obstetric & Gynecologic:


(5)

29.Brubaker L, et al. Pelvic organ prolapse. Incontinence. 2nd

International Consultation on Incontinence. 2nd ed. Plymouth (UK):

Plymouth Distributors [internet]; 2002: 243-265.

30.Hacker NF. Essentials of Obstetrics and Gynecology edisi 4.

Philadelphia: Elsevier Saunders; 2004.

31.Hasnawati A, Irianta T, Moeljono ER, Miskad UA, Bahar B.

Perbandingan Ekspresi Elastin Ligamentum Sakrouterina Pada

Perempuan Dengan Prolaps Organ Panggul dan Tanpa Prolaps Organ

Panggul. Bagian Obstetri dan Ginekologi Fakultas Kedokteran

Universitas Hasanuddin; 2012.

32.Hunskaar S, Burgio K, Clark A, Lapitain MC, Nelsom R, Sillen U, et

al. Epidemiology of Urinanry )UI) and Faecal (FI) Incontinence and

Pelvic Organ Prolapse (POP) chapter 5.

33.Thapa B, G. Rana, and S. Gurung. Contributing factors of

utero-vaginal prolapse among women attending in Bharatpur Hospital.

Journal of Chitwan Medical College [internet]. 2015; 4(3):38-42.

34.Schorge JO, Schaffer JI, Halvorson LM, Hoffman BL, Bradshaw KD,

Cunningham FG. Williams Gynecology. United States: Mc Graw Hill

Companies; 2008.

35.Mirhashemi Ramin, MD. Treatment of Pelvic Prolapse. Available

from: http://www.gynla.com/expertise/pelvic-prolapse-treatment.php

36.A service of the U.S. National Library of Medicine National Institutes


(6)

Available from:

http://www.nlm.nih.gov/medlineplus/ency/article/001508.htm

37.Junizaf, Santoso Budi Iman. Panduan Penatalaksanaan Prolaps Organ

Panggul. Himpunan Uroginekologi-POGI; 2013.

38.Persu C, Chapple CR, Cauni V, Gutue S, Geavlete P. Pelvic Organ

Prolapse Quantification System (POP-Q) – a new era in pelvic prolapse staging. Journal of Medicine and Life [internet]. 2011. [cited

2015 Feb 3]; 4(1):75‐81.

39.Kenny, Dr Beverley. Uterus Showing Prolapse (diagram). Egton

Medical Information Systems Limited [internet]. 2015. Available

from:

http://www.patient.co.uk/diagram/uterus-showing-prolapse-diagram

40.Zulfadli, Fauzi A, Azhari, Theodorus. Impact of Uterine Prolapse

Surgery on Improvement of Bowel Symptoms [internet]. 2014. [cited

2014 Des 13]; 2(3)

41.Shaw R, Luesley D, Monga A (eds). Urogynaecology section.

Gynaecology, 4th ed. London: Churchill Livingstone; 2010.

42.Downing Keith T. Uterine Prolapse: From Antiquity to Today.

Obstetrics and Gynecology International; 2012.

43.International Urogynecological Association. Pelvic Organ Prolapse: A

Guide for Women; 2011.

44.Suryaningdyah Dwika. Hubungan Paritas dengan Kejadian Proaps


(7)

45.Quiroz LH, Munoz A, Shippey SH, Gutman RE, Handa VL. “Vaginal Parity and Pelvic Organ Prolapse. Journal of Reproductive Medicine.

[internet]. 2010. [cited 2015 Jun 19]; 55(3-4):93-98.

46.Fritel X, Varnoux N, Zins M, Breart G, ringa V. Symptomatic Pelvic

Organ Prolapse at Midlife, Qualoty of Life and Risk Factors: The

American College of Obstetricians and Gynecologist. [internet]. 2009.

[cited 2015 Jun 20]; 113(2):609-616.

47.Scott J, Disaia Pj, Hammond CB, Spellacy N, Gordon JD. 2002. Buku

Saku Obstetri dan Ginekologi. Jakarta: Widya Medika.

48.Miedel A, Tegerstedt G, Schmidt M, Nyren O, Hammarstrom M.

Nonobstetric Risk Factors for Symptomatic Pelvic Organ Prolapse.

American College of Obstetricians and Gynecologist. [internet]. 2009.

[cited 2015 Jun 20]; 113(5):1089-1097.

49.Datta M, Randall L, Holmes N, Kamnaharan N. 2008. Rujukan Cepat


(8)

(9)

(10)

Lampiran 3. Output SPSS Analisis Univariat

Paritas

Frequency Percent Valid Percent Cumulative Percent

Valid

Multipara 46 82,1 82,1 82,1

Nulipara/Primipara 10 17,9 17,9 100,0

Total 56 100,0 100,0

Dae rah asal

42 75.0 75.0 75.0

14 25.0 25.0 100.0

56 100.0 100.0 Semarang

Luar Semarang Total

Valid

Frequency Percent Valid Percent

Cumulative Percent

Pekerjaan

11 19.6 19.6 19.6

45 80.4 80.4 100.0

56 100.0 100.0 Bekerja

Tidak bekerja Total

Valid

Frequency Percent Valid Percent

Cumulative Percent

Pendidikan

24 42.9 42.9 42.9

32 57.1 57.1 100.0

56 100.0 100.0 Dasar

Menengah/Tinggi Total

Valid

Frequency Percent Valid Percent

Cumulative Percent

Status perkawinan

55 98.2 98.2 98.2

1 1.8 1.8 100.0

56 100.0 100.0

Kawin Tidak kawin Total Valid

Frequency Percent Valid Percent

Cumulative Percent


(11)

BMI

Frequency Percent Valid Percent Cumulative Percent

Valid

>= 25 27 48,2 48,2 48,2

< 25 29 51,8 51,8 100,0

Total 56 100,0 100,0

Grade Prolaps Uteri

Frequency Percent Valid Percent Cumulative Percent

Valid

Grade 4 30 53,6 53,6 53,6

Grade 3 12 21,4 21,4 75,0

Grade 2 9 16,1 16,1 91,1

Grade 1 5 8,9 8,9 100,0

Total 56 100,0 100,0

Tindakan

Frequency Percent Valid Percent Cumulative Percent

Valid

Operatif 38 67,9 67,9 67,9

Non operatif 18 32,1 32,1 100,0

Total 56 100,0 100,0

11 19.6 19.6 100.0

56 100.0 100.0

< 50 tahun Total

Riw ayat haid

47 83.9 83.9 83.9

9 16.1 16.1 100.0

56 100.0 100.0

Menopause Belum Total Valid

Frequency Percent Valid Percent

Cumulative Percent


(12)

Crosstabs

1. Paritas * Diagnosis Prolaps Uteri Crosstab

Diagnosis PU Total Grade III - IV Grade I - II

Paritas

Multipara

Count 41 5 46

Expected Count 34,5 11,5 46,0 % within Diagnosis PU 97,6% 35,7% 82,1%

% of Total 73,2% 8,9% 82,1%

Nulipara/Primipara

Count 1 9 10

Expected Count 7,5 2,5 10,0

% within Diagnosis PU 2,4% 64,3% 17,9%

% of Total 1,8% 16,1% 17,9%

Total

Count 42 14 56

Expected Count 42,0 14,0 56,0 % within Diagnosis PU 100,0% 100,0% 100,0% % of Total 75,0% 25,0% 100,0%

Chi-Square Tests

Value df Asymp. Sig. (2-sided)

Exact Sig. (2-sided)

Exact Sig. (1-sided) Pearson Chi-Square 27,432a 1 ,000

Continuity Correctionb 23,374 1 ,000 Likelihood Ratio 24,852 1 ,000

Fisher's Exact Test ,000 ,000

Linear-by-Linear Association 26,942 1 ,000 N of Valid Cases 56

a. 1 cells (25,0%) have expected count less than 5. The minimum expected count is 2,50. b. Computed only for a 2x2 table

Risk Estimate

Value 95% Confidence Interval Lower Upper Odds Ratio for Paritas (Multipara /

Nulipara/Primipara)

73,800 7,663 710,785 For cohort Diagnosis PU = Grade III - IV 8,913 1,385 57,377 For cohort Diagnosis PU = Grade I - II ,121 ,051 ,283


(13)

2. Usia * Diagnosis Prolaps Uteri

Crosstab

41 4 45

33.8 11.3 45.0 97.6% 28.6% 80.4% 73.2% 7.1% 80.4%

1 10 11

8.3 2.8 11.0 2.4% 71.4% 19.6% 1.8% 17.9% 19.6%

42 14 56

42.0 14.0 56.0 100.0% 100.0% 100.0% 75.0% 25.0% 100.0% Count

Expected Count % within Diagnosis PU % of Total

Count

Expected Count % within Diagnosis PU % of Total

Count

Expected Count % within Diagnosis PU % of Total

>= 50 tahun

< 50 tahun Usia

Total

Grade III - IV Grade I - II Diagnosis PU

Total

Chi-Square Tests

31.714b 1 .000

27.491 1 .000

29.283 1 .000

.000 .000

31.148 1 .000

56 Pearson Chi-Square

Continuity Correctiona

Likelihood Ratio Fisher's Exact Test Linear-by-Linear Association N of Valid Cases

Value df Asymp. Sig. (2-sided) Exact Sig. (2-sided) Exact Sig. (1-sided)

Computed only for a 2x2 table a.

1 cells (25.0%) have expected count less than 5. The minimum expected count is 2. 75.

b.

Risk Estimate

102.500 10.300 1020.058

10.022 1.543 65.091

.098 .038 .254

56 Odds Ratio for Usia (>=

50 tahun / < 50 tahun) For cohort Diagnosis PU = Grade III - IV For cohort Diagnosis PU = Grade I - II N of Valid Cases

Value Lower Upper

95% Confidence Interval


(14)

3. Menopause * Diagnosis Prolaps Uteri

Crosstab

41 6 47

35.3 11.8 47.0

97.6% 42.9% 83.9%

73.2% 10.7% 83.9%

1 8 9

6.8 2.3 9.0

2.4% 57.1% 16.1%

1.8% 14.3% 16.1%

42 14 56

42.0 14.0 56.0

100.0% 100.0% 100.0%

75.0% 25.0% 100.0%

Count

Expected Count % within Diagnosis PU % of Total

Count

Expected Count % within Diagnosis PU % of Total

Count

Expected Count % within Diagnosis PU % of Total

Menopause

Belum Riwayat

haid

Total

Grade III - IV Grade I - II Diagnosis PU

Total

Chi-Square Tests

23.344b 1 .000

19.461 1 .000

20.803 1 .000

.000 .000

22.928 1 .000

56 Pearson Chi-Square

Continuity Correctiona

Likelihood Ratio Fisher's Exact Test Linear-by-Linear Association N of Valid Cases

Value df Asymp. Sig. (2-sided) Exact Sig. (2-sided) Exact Sig. (1-sided)

Computed only for a 2x2 table a.

1 cells (25.0%) have expected count less than 5. The minimum expected count is 2. 25.

b.

Risk Estimate

54.667 5.771 517.865

7.851 1.233 49.987

.144 .066 .314

56 Odds Ratio for Riwayat

haid (Menopause / Belum)

For cohort Diagnosis PU = Grade III - IV For cohort Diagnosis PU = Grade I - II N of Valid Cases

Value Lower Upper

95% Confidence Interval


(15)

4. BMI * Diagnosis Prolaps Uteri

Crosstab

21 6 27

20.3 6.8 27.0

50.0% 42.9% 48.2%

37.5% 10.7% 48.2%

21 8 29

21.8 7.3 29.0

50.0% 57.1% 51.8%

37.5% 14.3% 51.8%

42 14 56

42.0 14.0 56.0

100.0% 100.0% 100.0%

75.0% 25.0% 100.0%

Count

Expected Count

% within Diagnosis PU % of Total

Count

Expected Count

% within Diagnosis PU % of Total

Count

Expected Count

% within Diagnosis PU % of Total

>= 23

< 23 BMI

Total

Grade III - IV Grade I - II Diagnosis PU

Total

Chi-Square Tests

.215b 1 .643

.024 1 .877

.215 1 .643

.761 .440

.211 1 .646

56 Pearson Chi-Square

Continuity Correctiona

Likelihood Ratio Fisher's Exact Test Linear-by-Linear Association N of Valid Cases

Value df Asymp. Sig. (2-sided) Exact Sig. (2-sided) Exact Sig. (1-sided)

Computed only for a 2x2 table a.

0 cells (.0%) have expected count less than 5. The minimum expected count is 6. 75.

b.

Risk Estimate

1.333 .394 4.512

1.074 .794 1.453

.806 .321 2.021

56 Odds Ratio for BMI

(> = 23 / < 23)

For cohort Diagnosis PU = Grade III - IV For cohort Diagnosis PU = Grade I - II N of Valid Cases

Value Lower Upper

95% Confidence Interval


(16)

Logistic Regression

Variables in the Equation

42.787 49226.046 .000 1 .999 4E+018 .000 . -19.257 40192.887 .000 1 1.000 .000 .000 .

-19.257 28420.710 .000 1 .999 .000 .000 .

-6.600 1.497 19.446 1 .000 .001

23.530 28420.716 .000 1 .999 2E+010 .000 .

-19.123 28420.716 .000 1 .999 .000 .000 .

-6.734 1.491 20.403 1 .000 .001

4.630 1.172 15.596 1 .000 102.500 10.300 1020.058 -6.957 1.482 22.025 1 .000 .001

Usia Paritas Haid Constant Step

1a

Usia Haid Constant Step

2a

Usia Constant Step

3a

B S.E. Wald df Sig. Exp(B) Lower Upper

95.0% C.I.for EXP(B)

Variable(s) entered on step 1: Usia, Paritas, Haid. a.


(17)

Lampiran 4. Identitas mahasiswa

IDENTITAS MAHASISWA

Nama : Baiq Cipta Hardianti

NIM : 22010111140197

Tempat/tanggal lahir : Sintung, 13 Juli 1993

Jenis kelamin : Perempuan

Alamat : Sintung, Kecamatan Pringgarata, Lombok Tengah, NTB

Nomor HP : 087864092298 / 085713421504

E-mail : baiqcipta@ymail.com

Riwayat Pendidikan Formal

1. SD : SD Negeri Esot Lulus tahun : 2005

2. SMP : SMP Negeri 1 Narmada Lulus tahun : 2008

3. SMA : SMA Negeri 1 Mataram Lulus tahun : 2011


(1)

Crosstabs

1.

Paritas * Diagnosis Prolaps Uteri

Crosstab

Diagnosis PU Total

Grade III - IV Grade I - II

Paritas

Multipara

Count 41 5 46

Expected Count 34,5 11,5 46,0

% within Diagnosis PU 97,6% 35,7% 82,1%

% of Total 73,2% 8,9% 82,1%

Nulipara/Primipara

Count 1 9 10

Expected Count 7,5 2,5 10,0

% within Diagnosis PU 2,4% 64,3% 17,9%

% of Total 1,8% 16,1% 17,9%

Total

Count 42 14 56

Expected Count 42,0 14,0 56,0

% within Diagnosis PU 100,0% 100,0% 100,0%

% of Total 75,0% 25,0% 100,0%

Chi-Square Tests

Value df Asymp. Sig. (2-sided)

Exact Sig. (2-sided)

Exact Sig. (1-sided)

Pearson Chi-Square 27,432a 1 ,000

Continuity Correctionb 23,374 1 ,000

Likelihood Ratio 24,852 1 ,000

Fisher's Exact Test ,000 ,000

Linear-by-Linear Association 26,942 1 ,000

N of Valid Cases 56

a. 1 cells (25,0%) have expected count less than 5. The minimum expected count is 2,50. b. Computed only for a 2x2 table

Risk Estimate

Value 95% Confidence Interval

Lower Upper

Odds Ratio for Paritas (Multipara / Nulipara/Primipara)

73,800 7,663 710,785

For cohort Diagnosis PU = Grade III - IV 8,913 1,385 57,377

For cohort Diagnosis PU = Grade I - II ,121 ,051 ,283


(2)

2.

Usia * Diagnosis Prolaps Uteri

Crosstab

41 4 45

33.8 11.3 45.0

97.6% 28.6% 80.4%

73.2% 7.1% 80.4%

1 10 11

8.3 2.8 11.0

2.4% 71.4% 19.6%

1.8% 17.9% 19.6%

42 14 56

42.0 14.0 56.0

100.0% 100.0% 100.0%

75.0% 25.0% 100.0%

Count

Expected Count % within Diagnosis PU % of Total

Count

Expected Count % within Diagnosis PU % of Total

Count

Expected Count % within Diagnosis PU % of Total

>= 50 tahun

< 50 tahun Usia

Total

Grade III - IV Grade I - II Diagnosis PU

Total

Chi-Square Tests

31.714b 1 .000

27.491 1 .000

29.283 1 .000

.000 .000

31.148 1 .000

56 Pearson Chi-Square

Continuity Correctiona Likelihood Ratio Fisher's Exact Test Linear-by-Linear Association N of Valid Cases

Value df

Asymp. Sig. (2-sided)

Exact Sig. (2-sided)

Exact Sig. (1-sided)

Computed only for a 2x2 table a.

1 cells (25.0%) have expected count less than 5. The minimum expected count is 2. 75.

b.

Risk Estimate

102.500 10.300 1020.058

10.022 1.543 65.091

.098 .038 .254

56 Odds Ratio for Usia (>=

50 tahun / < 50 tahun) For cohort Diagnosis PU = Grade III - IV For cohort Diagnosis PU = Grade I - II N of Valid Cases

Value Lower Upper

95% Confidence Interval


(3)

3.

Menopause * Diagnosis Prolaps Uteri

Crosstab

41 6 47

35.3 11.8 47.0

97.6% 42.9% 83.9%

73.2% 10.7% 83.9%

1 8 9

6.8 2.3 9.0

2.4% 57.1% 16.1%

1.8% 14.3% 16.1%

42 14 56

42.0 14.0 56.0

100.0% 100.0% 100.0%

75.0% 25.0% 100.0%

Count

Expected Count % within Diagnosis PU % of Total

Count

Expected Count % within Diagnosis PU % of Total

Count

Expected Count % within Diagnosis PU % of Total

Menopause

Belum Riwayat

haid

Total

Grade III - IV Grade I - II Diagnosis PU

Total

Chi-Square Tests

23.344b 1 .000

19.461 1 .000

20.803 1 .000

.000 .000

22.928 1 .000

56 Pearson Chi-Square

Continuity Correctiona Likelihood Ratio Fisher's Exact Test Linear-by-Linear Association N of Valid Cases

Value df

Asymp. Sig. (2-sided)

Exact Sig. (2-sided)

Exact Sig. (1-sided)

Computed only for a 2x2 table a.

1 cells (25.0%) have expected count less than 5. The minimum expected count is 2. 25.

b.

Risk Estimate

54.667 5.771 517.865

7.851 1.233 49.987

.144 .066 .314

56 Odds Ratio for Riwayat

haid (Menopause / Belum)

For cohort Diagnosis PU = Grade III - IV For cohort Diagnosis PU = Grade I - II N of Valid Cases

Value Lower Upper

95% Confidence Interval


(4)

4.

BMI * Diagnosis Prolaps Uteri

Crosstab

21 6 27

20.3 6.8 27.0

50.0% 42.9% 48.2%

37.5% 10.7% 48.2%

21 8 29

21.8 7.3 29.0

50.0% 57.1% 51.8%

37.5% 14.3% 51.8%

42 14 56

42.0 14.0 56.0

100.0% 100.0% 100.0%

75.0% 25.0% 100.0%

Count

Expected Count

% within Diagnosis PU % of Total

Count

Expected Count

% within Diagnosis PU % of Total

Count

Expected Count

% within Diagnosis PU % of Total

>= 23

< 23 BMI

Total

Grade III - IV Grade I - II Diagnosis PU

Total

Chi-Square Tests

.215b 1 .643

.024 1 .877

.215 1 .643

.761 .440

.211 1 .646

56 Pearson Chi-Square

Continuity Correctiona Likelihood Ratio Fisher's Exact Test Linear-by-Linear Association N of Valid Cases

Value df

Asymp. Sig. (2-sided)

Exact Sig. (2-sided)

Exact Sig. (1-sided)

Computed only for a 2x2 table a.

0 cells (.0%) have expected count less than 5. The minimum expected count is 6. 75.

b.

Risk Estimate

1.333 .394 4.512

1.074 .794 1.453

.806 .321 2.021

56 Odds Ratio for BMI

(> = 23 / < 23)

For cohort Diagnosis PU = Grade III - IV For cohort Diagnosis PU = Grade I - II N of Valid Cases

Value Lower Upper

95% Confidence Interval


(5)

Logistic Regression

Variables in the Equation

42.787 49226.046 .000 1 .999 4E+018 .000 .

-19.257 40192.887 .000 1 1.000 .000 .000 .

-19.257 28420.710 .000 1 .999 .000 .000 .

-6.600 1.497 19.446 1 .000 .001

23.530 28420.716 .000 1 .999 2E+010 .000 .

-19.123 28420.716 .000 1 .999 .000 .000 .

-6.734 1.491 20.403 1 .000 .001

4.630 1.172 15.596 1 .000 102.500 10.300 1020.058

-6.957 1.482 22.025 1 .000 .001

Usia Paritas Haid Constant Step

1a

Usia Haid Constant Step

2a

Usia Constant Step

3a

B S.E. Wald df Sig. Exp(B) Lower Upper

95.0% C.I.for EXP(B)

Variable(s) entered on step 1: Usia, Paritas, Haid. a.


(6)

Lampiran 4. Identitas mahasiswa

IDENTITAS MAHASISWA

Nama

: Baiq Cipta Hardianti

NIM

: 22010111140197

Tempat/tanggal lahir : Sintung, 13 Juli 1993

Jenis kelamin

: Perempuan

Alamat

: Sintung, Kecamatan Pringgarata, Lombok Tengah, NTB

Nomor HP

: 087864092298 / 085713421504

E-mail

: baiqcipta@ymail.com

Riwayat Pendidikan Formal

1.

SD

: SD Negeri Esot

Lulus tahun

: 2005

2.

SMP

: SMP Negeri 1 Narmada

Lulus tahun

: 2008

3.

SMA

: SMA Negeri 1 Mataram

Lulus tahun

: 2011